JPMorgan Chase & Co’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-1
| Closed | – | – | 6419 |
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6280 |
|
2022
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6140 |
|
2019
Q4 | – | Sell |
-27,216
| Closed | -$286K | – | 4930 |
|
2019
Q3 | $286K | Sell |
27,216
-310,899
| -92% | -$3.27M | ﹤0.01% | 3588 |
|
2019
Q2 | $6.73M | Sell |
338,115
-80,887
| -19% | -$1.61M | ﹤0.01% | 1965 |
|
2019
Q1 | $14.1M | Buy |
419,002
+19,423
| +5% | +$655K | ﹤0.01% | 1530 |
|
2018
Q4 | $11.7M | Buy |
399,579
+12,139
| +3% | +$354K | ﹤0.01% | 1576 |
|
2018
Q3 | $23.9M | Buy |
387,440
+30,082
| +8% | +$1.85M | ﹤0.01% | 1327 |
|
2018
Q2 | $26.4M | Buy |
357,358
+71,054
| +25% | +$5.24M | 0.01% | 1225 |
|
2018
Q1 | $18.8M | Buy |
286,304
+52,397
| +22% | +$3.44M | ﹤0.01% | 1395 |
|
2017
Q4 | $19.7M | Buy |
233,907
+7,596
| +3% | +$639K | ﹤0.01% | 1390 |
|
2017
Q3 | $26.2M | Sell |
226,311
-20,364
| -8% | -$2.36M | 0.01% | 1181 |
|
2017
Q2 | $28.8M | Buy |
246,675
+22,767
| +10% | +$2.66M | 0.01% | 1105 |
|
2017
Q1 | $27.6M | Buy |
223,908
+11,448
| +5% | +$1.41M | 0.01% | 1130 |
|
2016
Q4 | $28.9M | Sell |
212,460
-10,946
| -5% | -$1.49M | 0.01% | 1088 |
|
2016
Q3 | $44.5M | Sell |
223,406
-12,133
| -5% | -$2.41M | 0.01% | 811 |
|
2016
Q2 | $30.5M | Sell |
235,539
-8,278
| -3% | -$1.07M | 0.01% | 994 |
|
2016
Q1 | $22.8M | Buy |
243,817
+61,688
| +34% | +$5.77M | 0.01% | 1134 |
|
2015
Q4 | $36.9M | Buy |
182,129
+62,962
| +53% | +$12.8M | 0.01% | 868 |
|
2015
Q3 | $17.3M | Buy |
119,167
+26,731
| +29% | +$3.88M | ﹤0.01% | 1238 |
|
2015
Q2 | $19.7M | Buy |
92,436
+5,966
| +7% | +$1.27M | ﹤0.01% | 1274 |
|
2015
Q1 | $20M | Buy |
86,470
+36,713
| +74% | +$8.51M | ﹤0.01% | 1313 |
|
2014
Q4 | $11.5M | Buy |
+49,757
| New | +$11.5M | ﹤0.01% | 1613 |
|